Gene transfer to the major salivary glands is an attractive method for the systemic delivery of therapeutic proteins. To date, nonviral gene transfer to these glands has resulted in inadequate ...
LEHI, UTAH / ACCESSWIRE / November 12, 2019 / Frelii, Inc. (OTC PINK:FRLI) ("Frelii" or the "Company"), a biotechnology company working to commercialize its patent-pending DNA gene sequencing ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the ...
There are few treatment options available for people with disorders of the esophagus. Delivering drugs directly to this part ...
Please provide your email address to receive an email when new articles are posted on . The FDA has approved a self-injectable formulation of Benlysta for patients with systemic lupus erythematosus, ...
The Wasan Laboratory in the Faculty of Pharmaceutical Sciences at the University of British Columbia in partnership with iCo Therapeutics Inc. (Vancouver BC, Canada) have developed a novel oral ...
The Wasan Laboratory in the Faculty of Pharmaceutical Sciences at the University of British Columbia in partnership with iCo Therapeutics Inc. (Vancouver BC, Canada) have developed a novel oral ...
Pre-IND Meeting on AQST-108 Completed FDA Confirmed AQST-108 To Be Reviewed Under 505(b)(2) No Additional Clinical Studies Would Be Required Prior to Opening Proposed IND Pivotal Pharmacokinetic (PK) ...
Highly potent but poorly water-soluble drug (PWSD) candidates are common outcomes of contemporary drug discovery programmes. These lipophilic compounds often exhibit poor systemic exposure following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results